Literature DB >> 2613169

Current status of pancreaticoduodenectomy for periampullary carcinoma.

D W Crist1, J L Cameron.   

Abstract

Pancreaticoduodenectomy has undergone numerous modifications since the original description by Whipple et al. of a successful two-stage radical resection of the head of the pancreas and duodenum in 1935. For most of the 50 years that the Whipple procedure has been performed, the morbidity and mortality rates have been high, and few long-term survivors have been reported. Over the past decade, a number of institutions have reported a dramatic decline in operative morbidity and mortality as well as an improved survival for those undergoing pancreaticoduodenal resection. Between 1969 and 1986, 88 patients underwent pancreaticoduodenal resection for periampullary cancer at the Johns Hopkins Hospital. In an effort to detect recent trends in operative morbidity and mortality for those undergoing pancreaticoduodenal resection, the patients were divided into two groups on the basis of two time periods. Forty-one patients underwent pancreaticoduodenectomy for periampullary cancer between 1969 and 1981, while 47 patients underwent pancreaticoduodenectomy between 1981 and 1986. There were no significant differences between the two groups in terms of mean age, sex distribution, duration of symptoms before presentation or mean weight loss. Likewise, preoperative laboratory data were similar for both groups of patients. In addition, mean tumor size was similar in both groups, as was the incidence of positive lymph nodes. Among the 41 patients operated upon during the first period, hospital morbidity and mortality rates were 59% and 24%, respectively. In contrast, hospital morbidity and mortality rates were 36% and 21%, respectively among the 47 patients operated upon during the recent period.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2613169

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

1.  Periampullary adenocarcinoma: analysis of 5-year survivors.

Authors:  B Gudjonsson
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

2.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.

Authors:  Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

3.  Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy: a prospective study.

Authors:  J D Roder; H J Stein; K A Böttcher; R Busch; C D Heidecke; J R Siewert
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

4.  Targeting early deaths following pancreaticoduodenectomy to improve survival.

Authors:  Whalen Clark; Melissa Silva; Natalie Donn; Kenneth Luberice; Leigh Ann Humphries; Harold Paul; Jonathan Hernandez; Sharona B Ross; Alexander Rosemurgy
Journal:  J Gastrointest Surg       Date:  2012-08-09       Impact factor: 3.452

5.  Hemorrhage after pancreatoduodenectomy.

Authors:  B Rumstadt; M Schwab; P Korth; M Samman; M Trede
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

6.  The Whipple resection for cancer in U.S. Department of Veterans Affairs Hospitals.

Authors:  T P Wade; A G el-Ghazzawy; K S Virgo; F E Johnson
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

7.  The experience of the minimally invasive (MI) fellowship-trained (FT) hepatic-pancreatic and biliary (HPB) surgeon: could the outcome of MI pancreatoduodenectomy for peri-ampullary tumors be better than open?

Authors:  Andrew A Gumbs; Elie Chouillard; Mohamed Abu Hilal; Roland Croner; Brice Gayet; Michel Gagner
Journal:  Surg Endosc       Date:  2020-11-04       Impact factor: 4.584

Review 8.  Pancreatic Cancer: 80 Years of Surgery-Percentage and Repetitions.

Authors:  Birgir Gudjonsson
Journal:  HPB Surg       Date:  2016-10-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.